Related Experiment Video
Updated: Mar 20, 2026

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
Published on: May 22, 2020
MiR-130a regulates neurite outgrowth and dendritic spine density by targeting MeCP2
Yunjia Zhang1,2, Mengmeng Chen1,2, Zilong Qiu3
1State Key Laboratory for Brain & Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Abstract:
MicroRNAs (miRNAs) are critical for both development and function of the central nervous system. Significant evidence suggests that abnormal expression of miRNAs is associated with neurodevelopmental disorders. MeCP2 protein is an epigenetic regulator repressing or activating gene transcription by binding to methylated DNA. Both loss-of-function and gain-of-function mutations in the MECP2 gene lead to neurodevelopmental disorders such as Rett syndrome, autism and MECP2 duplication syndrome. In this study, we demonstrate that miR-130a inhibits neurite outgrowth and reduces dendritic spine density as well as dendritic complexity. Bioinformatics analyses, cell cultures and biochemical experiments indicate that miR-130a targets MECP2 and down-regulates MeCP2 protein expression. Furthermore, expression of the wild-type MeCP2, but not a loss-of-function mutant, rescues the miR-130a-induced phenotype. Our study uncovers the MECP2 gene as a previous unknown target for miR-130a, supporting that miR-130a may play a role in neurodevelopment by regulating MeCP2. Together with data from other groups, our work suggests that a feedback regulatory mechanism involving both miR-130a and MeCP2 may serve to ensure their appropriate expression and function in neural development.
Insights
MicroRNAs (miRNAs) regulate neural development. This study shows miR-130a targets MECP2, impacting MeCP2 protein levels and neuronal structure, suggesting a role in neurodevelopmental disorders.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are crucial for central nervous system development and function.
- Aberrant miRNA expression is linked to neurodevelopmental disorders.
- MeCP2 protein, an epigenetic regulator, is implicated in disorders like Rett syndrome and autism due to mutations in the MECP2 gene.
Purpose of the Study:
- To investigate the role of miR-130a in neural development.
- To identify the targets of miR-130a in the context of neurodevelopment.
- To explore the relationship between miR-130a and MeCP2 in neural regulation.
Main Methods:
- Bioinformatics analysis to predict miR-130a targets.
- Cell culture experiments to assess the effects of miR-130a on neuronal morphology.
- Biochemical assays to confirm the interaction between miR-130a and MECP2.
- Rescue experiments using wild-type and mutant MeCP2.
Main Results:
- miR-130a was found to inhibit neurite outgrowth, reduce dendritic spine density, and decrease dendritic complexity.
- Bioinformatics and experimental data confirmed MECP2 as a direct target of miR-130a.
- Down-regulation of MeCP2 protein expression by miR-130a was observed.
- Expression of wild-type MeCP2, but not a loss-of-function mutant, rescued the miR-130a-induced neuronal phenotype.
Conclusions:
- This study identifies MECP2 as a novel target of miR-130a.
- miR-130a plays a role in neural development by regulating MeCP2.
- A feedback loop between miR-130a and MeCP2 may be essential for proper neural development.

